Atebimetinib with modified chemo led to 94% 6-month survival rates in first-line pancreatic cancer, with durable responses ...

Dr. Fong has focused on gene therapy for over two decades, engineering viruses and immune cells to kill cancer. His City of Hope team developed CF33, a cancer-fighting virus that has been shown to ...

Pancreatic cancer has earned the grim nickname “the silent killer” for good reason. By the time most patients experience symptoms, the disease has often progressed to an advanced stage where ...

City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the United States with ...

The initiative comes after NHS England partnered with Pancreatic Cancer UK last year to launch a first-of-its-kind tool, the Family History Checker, to help identify people with an inherited risk ...

Immuneering Corporation (NASDAQ:IMRX) stock rose 7% on Monday after the clinical-stage oncology company reported positive survival data from its ongoing Phase 2a trial evaluating atebimetinib in ...

City of Hope co-led the first study to demonstrate that characterizing genetic material near chromosomes forecasts how mutated, cancer-causing genes reengineer DNA and alter the tumor microenvironment ...

LOS ANGELES--(BUSINESS WIRE)--City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. with its National Medical Center named top 5 in the ...

The Clarence and Mary Lee Howard Foundation will host a special fundraising event during Labor Day Weekend this year called The Walk for Ben. This event will raise much needed funds for pancreatic ...

LOS ANGELES, June 17, 2025--City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center named a Top 5 ...